These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24020976)

  • 1. Glia: an important target for anti-inflammatory and antidepressant activity.
    Hashioka S; Miyaoka T; Wake R; Furuya M; Horiguchi J
    Curr Drug Targets; 2013 Oct; 14(11):1322-8. PubMed ID: 24020976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressants and neuroinflammation: Can antidepressants calm glial rage down?
    Hashioka S
    Mini Rev Med Chem; 2011 Jun; 11(7):555-64. PubMed ID: 21699486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
    Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
    Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's disease.
    Hashioka S; McGeer PL; Monji A; Kanba S
    Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):12-9. PubMed ID: 20021334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of microglial activation by achillolide A.
    Elmann A; Telerman A; Mordechay S; Erlank H; Rindner M; Kashman Y; Ofir R
    Planta Med; 2015 Feb; 81(3):215-21. PubMed ID: 25654405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel celecoxib analogues inhibit glial production of prostaglandin E2, nitric oxide, and oxygen radicals reverting the neuroinflammatory responses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide.
    Villa V; Thellung S; Bajetto A; Gatta E; Robello M; Novelli F; Tasso B; Tonelli M; Florio T
    Pharmacol Res; 2016 Nov; 113(Pt A):500-514. PubMed ID: 27667770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.
    Wilms H; Zecca L; Rosenstiel P; Sievers J; Deuschl G; Lucius R
    Curr Pharm Des; 2007; 13(18):1925-8. PubMed ID: 17584117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches.
    Van Eldik LJ; Thompson WL; Ralay Ranaivo H; Behanna HA; Martin Watterson D
    Int Rev Neurobiol; 2007; 82():277-96. PubMed ID: 17678967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.
    Skaper SD; Facci L; Barbierato M; Zusso M; Bruschetta G; Impellizzeri D; Cuzzocrea S; Giusti P
    Mol Neurobiol; 2015 Oct; 52(2):1034-42. PubMed ID: 26055231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline ameliorates inflammation in CUMS mice and inhibits TNF-α-induced inflammation in microglia cells.
    Lu Y; Xu X; Jiang T; Jin L; Zhao XD; Cheng JH; Jin XJ; Ma J; Piao HN; Piao LX
    Int Immunopharmacol; 2019 Feb; 67():119-128. PubMed ID: 30544065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders.
    Sanacora G; Banasr M
    Biol Psychiatry; 2013 Jun; 73(12):1172-9. PubMed ID: 23726152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression.
    Maes M
    Neuro Endocrinol Lett; 2008 Jun; 29(3):287-91. PubMed ID: 18580840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of the anti-inflammatory properties of curcumin in neurodegenerative diseases and depression.
    Tizabi Y; Hurley LL; Qualls Z; Akinfiresoye L
    Molecules; 2014 Dec; 19(12):20864-79. PubMed ID: 25514226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalpol attenuates the neurotoxicity induced by beta-amyloid(1-42) in cortical neuron-glia cultures.
    Jiang B; Du J; Liu JH; Bao YM; An LJ
    Brain Res; 2008 Jan; 1188():139-47. PubMed ID: 18022141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duality of Antidepressants and Neuroprotectants.
    Tizabi Y
    Neurotox Res; 2016 Jul; 30(1):1-13. PubMed ID: 26613895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target.
    Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Phenil-6,7-dihydroxy-isochroman inhibits inflammatory activation of microglia.
    Togna AR; Latina V; Trefiletti G; Guiso M; Moschini S; Togna GI
    Brain Res Bull; 2013 Jun; 95():33-9. PubMed ID: 23558156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation in Depression and the Potential for Anti-Inflammatory Treatment.
    Kohler O; Krogh J; Mors O; Benros ME
    Curr Neuropharmacol; 2016; 14(7):732-42. PubMed ID: 27640518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurodegenerative hypothesis of depression and the influence of antidepressant medications.
    Hall S; Parr BA; Hussey S; Anoopkumar-Dukie S; Arora D; Grant GD
    Eur J Pharmacol; 2024 Nov; 983():176967. PubMed ID: 39222740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel small-molecule agonist of PPAR-γ potentiates an anti-inflammatory M2 glial phenotype.
    Song GJ; Nam Y; Jo M; Jung M; Koo JY; Cho W; Koh M; Park SB; Suk K
    Neuropharmacology; 2016 Oct; 109():159-169. PubMed ID: 27288982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.